These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36007780)

  • 1. Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermia.
    McKiernan EP; Moloney C; Chaudhuri TR; Clerkin S; Behan K; Straubinger RM; Crean J; Brougham DF
    Acta Biomater; 2022 Oct; 152():393-405. PubMed ID: 36007780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
    Li J; Wu C; Hou P; Zhang M; Xu K
    Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents.
    Lartigue L; Hugounenq P; Alloyeau D; Clarke SP; Lévy M; Bacri JC; Bazzi R; Brougham DF; Wilhelm C; Gazeau F
    ACS Nano; 2012 Dec; 6(12):10935-49. PubMed ID: 23167525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diblock-copolymer-mediated self-assembly of protein-stabilized iron oxide nanoparticle clusters for magnetic resonance imaging.
    Tähkä S; Laiho A; Kostiainen MA
    Chemistry; 2014 Mar; 20(10):2718-22. PubMed ID: 24523066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tailor-made PEG coated iron oxide nanoparticles as contrast agents for long lasting magnetic resonance molecular imaging of solid cancers.
    Lazaro-Carrillo A; Filice M; Guillén MJ; Amaro R; Viñambres M; Tabero A; Paredes KO; Villanueva A; Calvo P; Del Puerto Morales M; Marciello M
    Mater Sci Eng C Mater Biol Appl; 2020 Feb; 107():110262. PubMed ID: 31761230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-Generating Iron Oxide Multigranule Nanoclusters for Enhancing Hyperthermic Efficacy in Tumor Treatment.
    Jeon S; Park BC; Lim S; Yoon HY; Jeon YS; Kim BS; Kim YK; Kim K
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):33483-33491. PubMed ID: 32614594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
    Liu XL; Ng CT; Chandrasekharan P; Yang HT; Zhao LY; Peng E; Lv YB; Xiao W; Fang J; Yi JB; Zhang H; Chuang KH; Bay BH; Ding J; Fan HM
    Adv Healthc Mater; 2016 Aug; 5(16):2092-104. PubMed ID: 27297640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.
    Yue-Jian C; Juan T; Fei X; Jia-Bi Z; Ning G; Yi-Hua Z; Ye D; Liang G
    Drug Dev Ind Pharm; 2010 Oct; 36(10):1235-44. PubMed ID: 20818962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.
    Deng LH; Jiang H; Lu FL; Wang HW; Pu Y; Wu CQ; Tang HJ; Xu Y; Chen TW; Zhu J; Shen CY; Zhang XM
    Int J Nanomedicine; 2021; 16():201-211. PubMed ID: 33447035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.
    Martina MS; Fortin JP; Ménager C; Clément O; Barratt G; Grabielle-Madelmont C; Gazeau F; Cabuil V; Lesieur S
    J Am Chem Soc; 2005 Aug; 127(30):10676-85. PubMed ID: 16045355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
    Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
    J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
    Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
    Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity.
    LaConte LE; Nitin N; Zurkiya O; Caruntu D; O'Connor CJ; Hu X; Bao G
    J Magn Reson Imaging; 2007 Dec; 26(6):1634-41. PubMed ID: 17968941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing corona effects: multiphosphonic acid poly(ethylene glycol) copolymers for stable stealth iron oxide nanoparticles.
    Torrisi V; Graillot A; Vitorazi L; Crouzet Q; Marletta G; Loubat C; Berret JF
    Biomacromolecules; 2014 Aug; 15(8):3171-9. PubMed ID: 25046557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Property-Function Relationships of Iron Oxide Multicore Nanoflowers in Magnetic Hyperthermia and Photothermia.
    Bertuit E; Benassai E; Mériguet G; Greneche JM; Baptiste B; Neveu S; Wilhelm C; Abou-Hassan A
    ACS Nano; 2022 Jan; 16(1):271-284. PubMed ID: 34963049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
    Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.